Recrutamento encerrado
FASE
Número Europeu 2018-002617-35
NCT -
BUL-5/ESD PEGASUS-1
Double-blind, randomised, placebo-controlled, phase IIa trial on the efficacy and tolerability of an 8-week treatment with two different doses of budesonide orodispersible tablets vs. placebo for prevention of oesophageal strictures in adult patients after endoscopic submucosal dissection
Detalhes
Destaques